Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1027979Generated: October 31, 2026

N,N'-Bis(tert-butoxycarbonyl)-1H-pyrazole-1-carboxamidine → [3-methyl-4-((1S,4S)-2-methyl-2,5-diazabicyclo[2.2.1]heptan-5-yl)phenyl][N,N-bis(tert-butoxycarbonyl)]guanidine

https://huagongshe.com/reaction/1027979

Reaction equation

Participants

RoleNameHCIDCharge
ReactantN,N'-Bis(tert-butoxycarbonyl)-1H-pyrazole-1-carboxamidineHCID 4428040—
Reactant3-Methyl-4-[(1S,4S)-5-methyl-2,5-diazabicyclo[2.2.1]hept-2-yl]anilineHCID 68633306—
SolventWaterHCID 962—
SolventDimethylformamideHCID 6228—
Product[3-methyl-4-((1S,4S)-2-methyl-2,5-diazabicyclo[2.2.1]heptan-5-yl)phenyl][N,N-bis(tert-butoxycarbonyl)]guanidineHCID 68983667—

Reaction Steps

Compound (Da), 3-methyl-4-[(1S,4S)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]aniline, (0.105 g, 0.6 mmol) and 1-(tert-butoxycarbonylamino(tert-butoxycarbonylimino)methyl)pyrazole (H) (0.186 g, 0.6 mmol) were combined in DMF (2 mL) and stirred at ambient temperature for 3 days. The reaction was monitored by LCMS. The homogenous reaction mixture was then diluted with water (20 mL), the solid precipitate formed was isolated by filtration, and purified by column chromatography (silica gel, CH2Cl2 then 2-5% MeOH in CH2Cl2) to give [3-methyl-4-((1S,4S)-2-methyl-2,5-diazabicyclo[2.2.1]heptan-5-yl)phenyl][N,N-bis(tert-butoxycarbonyl)]guanidine; LCMS: purity: 99%; MS (m/e): 460 (MH+).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08735418B2
Source datasetuspto-grants-2014_05
ORD IDord-38eeb20a7e6d454b97a722d7c0dcafb9
Source noteuspto-grants-2014_05